Safety first: Tracking adverse events associated with new therapies for people with hemophilia.

Safety first: Tracking adverse events associated with new therapies for people with hemophilia. J Thromb Haemost. 2021 Jan;19 Suppl 1:3-5 Authors: Recht M PMID: 33331044 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33331044?dopt=Abstract

Source: Thrombosis and Haemostasis - December 19, 2020 Category: Hematology Authors: Recht M Tags: J Thromb Haemost Source Type: research

More News: Haemophilia | Hematology | Hemophilia | Thrombosis